BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9131139)

  • 1. Implication of PAF and acetylhydrolase (PAF-AH) activity in periodontal disease.
    Baltas G; Kotsifaki H; Antonopoulou S; Kipioti A; Demopoulos CA
    Adv Exp Med Biol; 1996; 416():135-41. PubMed ID: 9131139
    [No Abstract]   [Full Text] [Related]  

  • 2. Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases.
    Emingil G; Cinarcik S; Baylas H; Hüseyinov A
    J Periodontol; 2001 Aug; 72(8):1032-7. PubMed ID: 11525434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients.
    Antonopoulou S; Tsoupras A; Baltas G; Kotsifaki H; Mantzavinos Z; Demopoulos CA
    Mediators Inflamm; 2003 Aug; 12(4):221-7. PubMed ID: 14514473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of platelet activating factor acetylhydrolase following phase I periodontal therapy.
    Keles GC; Cetinkaya BO; Pamuk F; Balli U
    West Indian Med J; 2013 Jan; 62(1):62-7. PubMed ID: 24171330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a platelet activating factor acetylhydrolase from rat adipocyte.
    Chroni A; Mavri-Vavayanni M
    Life Sci; 2000 Oct; 67(23):2807-25. PubMed ID: 11105997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a new endogenous platelet-activating factor-like molecule in gingival crevicular fluid.
    Antonopoulou S; Demopoulos CA; Argyropoulos D; Baltas G; Kotsifaki H; Diamanti-Kipioti A
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):791-4. PubMed ID: 9480892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor (PAF) and PAF acetylhydrolase activity in rat uterus and placenta during the late stages of pregnancy.
    Matsubara T; Yasuda K; Johnston JM; Sanezumi M; Okada H; Matsuoka S; Kanzaki H
    Biol Reprod; 1997 Apr; 56(4):885-90. PubMed ID: 9096869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
    McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
    Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor acetylhydrolase activity in bovine seminal plasma.
    Parks JE; Hough SR
    J Androl; 1993; 14(5):335-9. PubMed ID: 8288488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases.
    Dulioust A; Hilliquin P; Menkes CJ; Benveniste J; Arnoux B
    Scand J Rheumatol; 1992; 21(4):161-4. PubMed ID: 1529281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory actions of platelet-activating factor: control by PAF acetylhydrolase.
    Prescott SM
    J Investig Allergol Clin Immunol; 1997; 7(5):416. PubMed ID: 9416565
    [No Abstract]   [Full Text] [Related]  

  • 12. PAF, a putative mediator of oral inflammation.
    McManus LM; Pinckard RN
    Crit Rev Oral Biol Med; 2000; 11(2):240-58. PubMed ID: 12002818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAF and PAF acetylhydrolase in the nervous system.
    Hattori M; Aoki J; Arai H; Inoue K
    J Lipid Mediat Cell Signal; 1996 Sep; 14(1-3):99-102. PubMed ID: 8906551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of human plasma-type platelet-activating factor acetylhydrolase in two anaphylactic shock models.
    Fukuda Y; Kawashima H; Saito K; Inomata N; Matsui M; Nakanishi T
    Eur J Pharmacol; 2000 Feb; 390(1-2):203-7. PubMed ID: 10708725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation.
    Svetlov SI; Howard KM; Miwa M; Flickinger BD; Olson MS
    Arch Biochem Biophys; 1996 Mar; 327(1):113-22. PubMed ID: 8615681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia.
    Jehle R; Schlame M; Büttner C; Frey B; Sinha P; Rüstow B
    Biochim Biophys Acta; 2001 May; 1532(1-2):60-6. PubMed ID: 11420174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage.
    Triggiani M; De Marino V; Sofia M; Faraone S; Ambrosio G; Carratù L; Marone G
    Am J Respir Crit Care Med; 1997 Jul; 156(1):94-100. PubMed ID: 9230731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor (PAF) acetylhydrolase activity, LIS1 expression, and seizures.
    Shmueli O; Cahana A; Reiner O
    J Neurosci Res; 1999 Jul; 57(2):176-84. PubMed ID: 10398295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activating factor degradation in tear fluid from guinea pigs with allergic conjunctivitis.
    Kato M; Mano H; Ota A; Konomi K; Nakata K
    J Ocul Pharmacol Ther; 2001 Feb; 17(1):83-91. PubMed ID: 11327052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated mast cells release extracellular type platelet-activating factor acetylhydrolase that contributes to autocrine inactivation of platelet-activating factor.
    Nakajima K; Murakami M; Yanoshita R; Samejima Y; Karasawa K; Setaka M; Nojima S; Kudo I
    J Biol Chem; 1997 Aug; 272(32):19708-13. PubMed ID: 9242626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.